Search results for "DECLINE"

showing 10 items of 261 documents

Nasal tactile sensitivity in elderly

2010

Conclusion: Although older people varied widely in tactile sensitivity, our results show that tactile thresholds increased with age. Objectives: The aim of this study was to evaluate the effects of aging on nasal tactile sensitivity. Methods: A total of 160 healthy patients aged between 50 and 90 years were included. According to their age, patients were divided into groups (A, B, C, D, E, F, G, and H). From the age of 50, each group included subjects with an age range of 5 years (i.e. group A, 50-55 years; group B, 56-60 years, etc.). Each patient's outcome was assessed through the nasal monofilament test: a set of 20 Semmes-Weinstein monofilaments was used to detect nasal sensitivity for …

Malemedicine.medical_specialtyAgingMonofilament test; aging process; sensory lossTurbinates markerssensory lossMonofilament test aging process sensory lossReference Valuesaging processMedicineHumansNoseAgedAged 80 and overbusiness.industry eventSensory lossGeneral MedicineMiddle AgedMonofilament test; aging process; sensory loss; age-related decline; markers; nerve; event; nose; pain nerveSurgerySettore MED/31 - Otorinolaringoiatriamedicine.anatomical_structureOtorhinolaryngologyTouchage-related declineAnesthesiaReference valuesSensory ThresholdsFemale noseNasal CavityMonofilament test painbusinessOlder people
researchProduct

Blood pressure and pulse wave velocity values in the institutionalized elderly aged 80 and over: baseline of the PARTAGE study.

2009

The aim of the longitudinal study PARTAGE (predictive values of blood pressure and arterial stiffness in institutionalized very aged population) was to determine the predictive value of blood pressure (BP) and arterial stiffness for overall mortality, major cardiovascular events and cognitive decline in a large population of institutionalized patients aged 80 and over. In the study herein, we present the baseline data values of this study.A total of 1130 patients were recruited (878 women), living in French and Italian nursing homes. Clinical and 3-day self-measurements of BP were conducted. Aortic and upper limb pulse wave velocity were obtained using a PulsePen tonometer.Of this populatio…

Malemedicine.medical_specialtyAgingPhysiologypulse wave velocityPopulationHemodynamicsBlood PressureHeart RatePredictive Value of TestsInternal medicineInternal MedicinemedicineHomes for the AgedHumansLongitudinal StudiesCognitive declineeducationPulse wave velocityAntihypertensive AgentsAortablodd pressure; pulse wave velocity; agingAged 80 and overblodd pressureeducation.field_of_studybusiness.industryBlood Pressure Determinationmedicine.diseasePulse pressureSurgeryNursing HomesSelf CareBlood pressureItalyPredictive value of testsPulsatile FlowBlood CirculationHypertensionArterial stiffnessCardiologyFemaleFranceCardiology and Cardiovascular MedicinebusinessBlood Flow VelocityJournal of hypertension
researchProduct

Orthostatic Changes in Blood Pressure and Cognitive Status in the Elderly: The Progetto Veneto Anziani Study.

2016

We studied a cohort of 1408 older subjects to explore whether postural changes in blood pressure (BP; defined as orthostatic hypo- or hypertension) can predict the onset of cognitive deterioration. Orthostatic hypotension was defined as a drop of 20 mm Hg in systolic or 10 mm Hg in diastolic BP and orthostatic hypertension as a rise of 20 mm Hg in systolic BP. Orthostatic BP values were grouped into quintiles for secondary analyses. Two cognitive assessments were considered: (1) cognitive impairment, that is, Mini-Mental State Examination scores ≤24/30, and (2) cognitive decline (CD), that is, a 3-point decrease in Mini-Mental State Examination score from the baseline to the follow-up. At t…

Malemedicine.medical_specialtyAgingPostureDiastoleBlood Pressure030204 cardiovascular system & hematologyNeuropsychological TestselderlyRisk AssessmentNOorthostatic hypotension03 medical and health sciencesOrthostatic vital signsHypotension Orthostatic0302 clinical medicineCognitionInternal medicinemedicineInternal MedicinePrevalenceHumansCognitive DysfunctionCognitive declinecognitive impairmentAgedorthostatic hypertensionPsychiatric Status Rating Scalesbusiness.industryConfoundingBlood Pressure DeterminationOdds ratioPrognosisBlood pressureItalyCohortHypertensionCardiologyPhysical therapyFemaleblood pressure; cognition; cognitive impairment; elderly; orthostatic hypertension; orthostatic hypotension; Internal MedicineOrthostatic hypertensionmedicine.symptombusinessCognition Disorders030217 neurology & neurosurgeryHypertension (Dallas, Tex. : 1979)
researchProduct

Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient : design of the Euro…

2014

BACKGROUND AND OBJECTIVES:: The SBP values to be achieved by antihypertensive therapy in order to maximize reduction of cardiovascular outcomes are unknown; neither is it clear whether in patients with a previous cardiovascular event, the optimal values are lower than in the low-to-moderate risk hypertensive patients, or a more cautious blood pressure (BP) reduction should be obtained. Because of the uncertainty whether 'the lower the better' or the 'J-curve' hypothesis is correct, the European Society of Hypertension and the Chinese Hypertension League have promoted a randomized trial comparing antihypertensive treatment strategies aiming at three different SBP targets in hypertensive pati…

Malemedicine.medical_specialtyChinaPhysiologyBlood Pressurelaw.inventionchemistry.chemical_compoundCognitionRandomized controlled triallawRecurrenceInternal medicineInternal MedicinemedicineSecondary Preventionblood pressure; cognitive decline; low-density lipoprotein cholesterol; randomized controlled trial; secondary prevention; strokeDementiaHumansProspective StudiesCognitive declineProspective cohort studyStrokeAntihypertensive AgentsAgedLdl cholesterolCholesterolbusiness.industryBlood Pressure DeterminationCholesterol LDLlipoprotein cholesterol randomized controlled trial secondary prevention strokeMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREmedicine.diseaseblood pressure cognitive decline low-densityEuropeStrokeBlood pressurechemistryIschemic Attack TransientHypertensionPhysical therapyCardiologyDementiaHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessCognition Disorders
researchProduct

Glycemic Dysregulations Are Associated With Worsening Cognitive Function in Older Participants at High Risk of Cardiovascular Disease: Two-Year Follo…

2021

The authors wish to thank the PREDIMED-Plus participants and staff for their engagement, as well as to the primary care centers involved in the study. We also thank the Cerca Programme of the Generalitat de Catalunya, and the CIBEROBN, CIBERESP and CIBERDEM initiatives of Instituto de Salud Carlos III in Spain, and the collaborators in the PRIME consortium for helpful input. The first version of the present article has been published in the public repository Research Square as a preprint publication of our work (44). We particularly thank Stephanie Nishi for her assistance with manuscript language revision.

Malemedicine.medical_specialtyCognition disordersEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismGlycemic ControlprediabetesType 2 diabetesdiabetes durationTrastorns de la cognicióDiseases of the endocrine glands. Clinical endocrinology03 medical and health scienceschemistry.chemical_compoundCognitionEndocrinology0302 clinical medicineInsulin resistanceinsulin resistanceDiabetes mellitusInternal medicinemedicineHumansHypoglycemic AgentsCognitive DysfunctionProspective StudiesPrediabetesglycated (glycosylated) hemoglobinCognitive declinecognitive functionAgedGlucose Metabolism DisordersOriginal ResearchGlycemicDiabetisbusiness.industryMalalties cardiovascularsDiabetesMiddle AgedRC648-665medicine.disease3. Good healthCardiovascular diseaseschemistryFemaletype 2 diabetesGlycated hemoglobinMetabolic syndromebusiness030217 neurology & neurosurgery
researchProduct

Laboratory-Based Gait Variability and Habitual Gait Entropy Do Not Differentiate Community-Dwelling Older Adults from Those with Subjective Memory Co…

2019

Background: Age-related cognitive decline may be delayed with appropriate interventions if those at high risk can be identified prior to clinical symptoms arising. Gait variability assessment has emerged as a promising candidate prognostic indicator, however, it remains unclear how sensitive gait variability is to early changes in cognitive abilities. Research question: Do community-dwelling adults over 65 years of age with subjective memory complaints differ from those with no subjective memory concerns in terms of laboratory-measured or free-living gait variability? Methods: This cross-sectional study recruited 24 (age = 73.5(SD 6.4) years) community-dwelling people with subjective memory…

Malemedicine.medical_specialtyEntropyBiophysicsPsychological interventionSubjective memorygaitwearable03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationMemoryAccelerometrymedicineDementiaHumansOrthopedics and Sports MedicineCognitive DysfunctionCognitive declineGaitcognitive impairmentAgedAged 80 and overbusiness.industryscreeningactivityRehabilitationCognition030229 sport sciencesStride lengthmedicine.diseaseSample entropyCross-Sectional StudiesDementiaFemaleAnalysis of varianceIndependent LivingbusinessGait Analysishuman activities030217 neurology & neurosurgeryGaitposture
researchProduct

A cross-sectional and longitudinal study on the protective effect of bilingualism against dementia using brain atrophy and cognitive measures.

2020

Abstract Background Evidence from previous studies suggests that bilingualism contributes to cognitive reserve because bilinguals manifest the first symptoms of Alzheimer’s disease (AD) up to 5 years later than monolinguals. Other cross-sectional studies demonstrate that bilinguals show greater amounts of brain atrophy and hypometabolism than monolinguals, despite sharing the same diagnosis and suffering from the same symptoms. However, these studies may be biased by possible pre-existing between-group differences. Methods In this study, we used global parenchymal measures of atrophy and cognitive tests to investigate the protective effect of bilingualism against dementia cross-sectionally …

Malemedicine.medical_specialtyLongitudinal studyBrain atrophyRegion-based morphometryNeurologyBilingualismCognitive NeuroscienceCognitive reserveMultilingualismAudiology050105 experimental psychologylcsh:RC346-429lcsh:RC321-57103 medical and health sciences0302 clinical medicineAtrophymedicineHumansDementia0501 psychology and cognitive sciencesLongitudinal StudiesCognitive declinelcsh:Neurosciences. Biological psychiatry. Neuropsychiatrylcsh:Neurology. Diseases of the nervous systemAgedCognitive reserveBilingüismebusiness.industryResearch05 social sciencesBrainMild cognitive impairmentCognitionMiddle AgedAlzheimer's diseasemedicine.diseaseCognitive testCross-Sectional StudiesMalaltia d'AlzheimerNeurologyDementiaFemaleNeurology (clinical)AtrophybusinessAlzheimer’s disease030217 neurology & neurosurgery
researchProduct

Pain is not associated with cognitive decline in older adults: A four-year longitudinal study.

2018

The finding of a potential association between pain and cognitive decline is limited to a few cross-sectional studies with relatively samples. We therefore aimed to investigate whether the presence and severity of pain at baseline could predict a decline in cognitive function over four years of follow-up in the English Longitudinal Study of Ageing. At baseline, participants with no dementia who were “often troubled by pain” were considered to have pain. Pain severity was categorized as mild, moderate, or severe. Cognitive function was explored through verbal fluency (assessed by asking how many different animals the participants could name in 60 s), memory (sum of immediate and delayed verb…

Malemedicine.medical_specialtyLongitudinal studyCognitive declinePainNeuropsychological TestsAudiologyArticleGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineElderlyMemoryHumansMedicineDementiaVerbal fluency testCognitive DysfunctionLongitudinal Studies030212 general & internal medicineCognitive declineAssociation (psychology)AgedAged 80 and overbusiness.industryConfoundingObstetrics and GynecologyCognitionMiddle Agedmedicine.diseaseAgeingLinear ModelsDementiaFemaleIndependent LivingPain Memory Cognitive decline Elderlbusiness030217 neurology & neurosurgery
researchProduct

Effect of a 2-year diet intervention with walnuts on cognitive decline. The Walnuts And Healthy Aging (WAHA) study: a randomized controlled trial

2019

Background Walnut consumption counteracts oxidative stress and inflammation, 2 drivers of cognitive decline. Clinical data concerning effects on cognition are lacking. Objectives The Walnuts And Healthy Aging study is a 2-center (Barcelona, Spain; Loma Linda, CA) randomized controlled trial examining the cognitive effects of a 2-y walnut intervention in cognitively healthy elders. Methods We randomly allocated 708 free-living elders (63-79 y, 68% women) to a diet enriched with walnuts at ∼15% energy (30-60 g/d) or a control diet (abstention from walnuts). We administered a comprehensive neurocognitive test battery at baseline and 2 y. Change in the global cognition composite was the primary…

Malemedicine.medical_specialtyMedicine (miscellaneous)Juglanslaw.inventionHealthy Aging03 medical and health sciences0302 clinical medicineRandomized controlled trialMemorylawInternal medicineIntervention (counseling)medicineHumansNutsCognitive Dysfunction030212 general & internal medicineCognitive declineAgedNutrition and DieteticsIntention-to-treat analysismedicine.diagnostic_testbusiness.industryBrainCognitionNeuropsychological testMiddle AgedMagnetic Resonance ImagingSpainCohortFemalebusinessNeurocognitive030217 neurology & neurosurgeryThe American Journal of Clinical Nutrition
researchProduct

Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence.

2014

BACKGROUND AND OBJECTIVES:: It is well established by a large number of randomized controlled trials that lowering blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) by drugs are powerful means to reduce stroke incidence, but the optimal BP and LDL-C levels to be achieved are largely uncertain. Concerning BP targets, two hypotheses are being confronted: first, the lower the BP, the better the treatment outcome, and second, the hypothesis that too low BP values are accompanied by a lower benefit and even higher risk. It is also unknown whether BP lowering and LDL-C lowering have additive beneficial effects for the primary and secondary prevention of stroke, and whether these…

Malemedicine.medical_specialtyPhysiologyHypercholesterolemiaLow density lipoprotein cholesterolBlood Pressurelaw.inventionCognitionRandomized controlled triallawRecurrenceInternal medicineblood pressure cognitive decline low-density lipoprotein cholesterol primary prevention secondary prevention strokeInternal MedicineSecondary PreventionMedicineHumansCognitive declineStrokeBeneficial effectsRandomized Controlled Trials as TopicSecondary preventionbusiness.industryMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARECholesterol LDLmedicine.diseasePrimary PreventionStrokeBlood pressureCholesterolCardiologyPhysical therapylipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicinebusinessStroke incidenceCognition Disordersblood pressure; cognitive decline; low-density lipoprotein cholesterol; primary prevention; secondary prevention; strokeJournal of hypertension
researchProduct